Evaluation of IL10, IL19 and IL20 gene polymorphisms and chronic hepatitis B infection outcome

International Journal of Immunogenetics

Volumn 35, Issue 3, 2008, Pages 255-264

  Truelove, Ann L ^a,b   Oleksyk, Taras K ^a,b   Shrestha, Sadeep ^a,b,g   Thio, Chloe L ^c   Goedert, James J ^d   Donfield, Sharyne M ^e   Kirk, Gregory D ^f   Thomas, David L ^c,f   O'Brien, Stephen J ^a   Smith, Michael W ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e RHO INC   (United States)

^f JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^g UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 19; INTERLEUKIN 20;

ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DNA POLYMORPHISM; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HEPATITIS B; HETEROZYGOSITY; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; PATHOGENESIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

AFRICAN AMERICANS; CASE-CONTROL STUDIES; DISEASE PROGRESSION; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENOTYPE; HAPLOTYPES; HEPATITIS B, CHRONIC; HUMANS; INTERLEUKIN-10; INTERLEUKINS; POLYMORPHISM, SINGLE NUCLEOTIDE;

HEPATITIS B VIRUS;

EID: 43549125805     PISSN: 17443121     EISSN: 1744313X     Source Type: Journal    
DOI: 10.1111/j.1744-313X.2008.00770.x     Document Type: Article

References (54)

1. Altshuler, D., Brooks, L.D., Chakravarti, A., Collins, F.S., Daly, M.J. Donnelly, P. (2005) A haplotype map of the human genome. Nature, 437, 1299.
2. de Bakker, P.I., Yelensky, R., Pe'er, I., Gabriel, S.B., Daly, M.J. Altshuler, D. (2005) Efficiency and power in genetic association studies. Nature Genetics, 37, 1217.
3. Bonferroni, C.E. (1935) Il calcolo delle assicurazioni su gruppi di teste. Studi in Onore del Professore Salvatore Ortu Carboni, 13.
4. Breslow, N.E. Day, N.E. (1980) Statistical Methods in Cancer Research, Vol. I: The Analysis of Case-control Studies. IARC Science Publications, 5. The International Agency for Research on Cancer, Lyon, France.
5. Centers for Disease Control and Prevention (2002) Viral Hepatitis and Injection Drug Users, Fact Sheet Series. CDC, Atlanta, GA.
6. Cheong, J.Y., Cho, S.W., Hwang, I.L., Yoon, S.K., Lee, J.H., Park, C.S., Lee, J.E., Hahm, K.B. Kim, J.H. (2006) Association between chronic hepatitis B virus infection and interleukin-10, tumor necrosis factor-α gene promoter polymorphisms. Journal of Gastroenterology and Hepatology, 21, 1163.
7. Crawley, E., Kay, R., Sillibourne, J., Patel, P., Hutchinson, I. Woo, P. (1999) Polymorphic haplotypes of the interleukin-10, 5′ flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis and Rheumatism, 42, 1101.
8. Dean, M., Stephens, J.C., Winkler, C., Lomb, D.A., Ramsburg, M., Boaze, R. et al 1994) Polymorphic admixture typing in human ethnic populations. American Journal of Human Genetics, 55, 788.
9. Duggal, P., Winkler, C.A., An, P., Yu, X.F., Farzadegan, H., O'Brien, S.J., Beaty, T.H. Vlahov, D. (2005) The effect of RANTES chemokine genetic variants on early HIV-1 plasma RNA among African American injection drug users. Journal of Acquired Immune Deficiency Syndromes, 38, 584.
10. Edwards-Smith, C.J., Jonsson, J.R., Purdie, D.M., Bansal, A., Shorthouse, C. Powell, E.E. (1999) Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa. Hepatology, 30, 526.
11. Eskdale, J., Gallagher, G., Verweij, C.L., Keijsers, V., Westendorp, R.G. Huizinga, T.W. (1998) Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proceedings of the National Academy of Sciences of the USA, 95, 9465.
12. Excoffier, L. Slatkin, M. (1995) Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Molecular Biology and Evolution, 12, 921.
13. Gibson, A.W., Edberg, J.C., Wu, J., Westendorp, R.G., Huizinga, T.W. Kimberly, R.P. (2001) Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. Journal of Immunology, 166, 3915.
14. Javanbakht, H., An, P., Gold, B., Petersen, D.C., O'Huigin, C., Nelson, G.W. et al 2006) Effects of human TRIM5α polymorphisms on antiretroviral function and susceptibility to human immunodeficiency virus infection. Virology, 354, 15.
15. Jung, S.H., Bang, H. Young, S. (2005) Sample size calculation for multiple testing in microarray data analysis. Biostatistics, 6, 157.
16. Karacki, P.S., Gao, X., Thio, C.L., Thomas, D.L., Goedert, J.J., Vlahov, D. et al 2004) MICA and recovery from hepatitis C virus and hepatitis B virus infections. Genes and Immunity, 5, 261.
17. Kartal, E.D., Colak, H., Ozgunes, I. Usluer, G. (2005) Exacerbation of psoriasis due to peginterferon alpha-2b plus ribavirin treatment of chronic active hepatitis C. Chemotherapy, 51, 167.
18. Ketikoglou, I., Karatapanis, S., Elefsiniotis, I., Kafiri, G. Moulakakis, A. (2005) Extensive psoriasis induced by pegylated interferon alpha-2b treatment for chronic hepatitis B. European Journal of Dermatology, 15, 107.
19. Kingo, K., Koks, S., Nikopensius, T., Silm, H. Vasar, E. (2004) Polymorphisms in the interleukin-20 gene: relationships to plaque-type psoriasis. Genes and Immunity, 5, 117.
20. Kingsley, L.A., Rinaldo, C.R. Jr., Lyter, D.W., Valdiserri, R.O., Belle, S.H. Ho, M. (1990) Sexual transmission efficiency of hepatitis B virus and human immunodeficiency virus among homosexual men. Journal of the American Medical Association, 264, 230.
21. Köks, S., Kingo, K., Ratsep, R., Karelson, M., Silm, H. Vasar, E. (2004) Combined haplotype analysis of the interleukin-19 and -20 genes: relationship to plaque-type psoriasis. Genes and Immunity, 5, 662.
22. Köks, S., Kingo, K., Vabrit, K., Ratsep, R., Karelson, M., Silm, H. Vasar, E. (2005) Possible relations between the polymorphisms of the cytokines IL-19, IL-20 and IL-24 and plaque-type psoriasis. Genes and Immunity, 6, 407.
23. Konopnicki, D., Mocroft, A., de Wit, S., Antunes, F., Ledergerber, B., Katlama, C., Zilmer, K., Vella, S., Kirk, O. Lundgren, J.D. (2005) Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort. AIDS, 19, 593.
24. Lai, C.L., Ratziu, V., Yuen, M.F. Poynard, T. (2003) Viral hepatitis B. Lancet, 362, 2089.
25. Levine, O.S., Vlahov, D., Brookmeyer, R., Cohn, S. Nelson, K.E. (1996) Differences in the incidence of hepatitis B and human immunodeficiency virus infections among injecting drug users. Journal of Infectious Diseases, 173, 579.
26. Liao, Y.C., Liang, W.G., Chen, F.W., Hsu, J.H., Yang, J.J. Chang, M.S. (2002) IL-19 induces production of IL-6 and TNF-α and results in cell apoptosis through TNF-α. Journal of Immunology, 169, 4288.
27. Lok, A.S. McMahon, B.J. (2004) Chronic hepatitis B: update of recommendations. Hepatology, 39, 857.
28. Migita, K., Miyazoe, S., Maeda, Y., Daikoku, M., Abiru, S., Ueki, T. et al 2005) Cytokine gene polymorphisms in Japanese patients with hepatitis B virus infection - association between TGF-β1 polymorphisms and hepatocellular carcinoma. Journal of Hepatology, 42, 505.
29. Miyazoe, S., Hamasaki, K., Nakata, K., Kajiya, Y., Kitajima, K., Nakao, K. et al 2002) Influence of interleukin-10 gene promoter polymorphisms on disease progression in patients chronically infected with hepatitis B virus. American Journal of Gastroenterology, 97, 2086.
30. Moore, K.W., de Waal Malefyt, R., Coffman, R.L. O'Garra, A. (2001) Interleukin-10 and the interleukin-10 receptor. Annual Review of Immunology, 19, 683.
31. Oleksyk, T.K., Thio, C.L., Truelove, A.L., Goedert, J.J., Donfield, S.M., Kirk, G.D., Thomas, D.L., O'Brien, S.J. Smith, M.W. (2005) Single nucleotide polymorphisms and haplotypes in the IL10 region associated with HCV clearance. Genes and Immunity, 6, 347.
32. Oral, H.B., Kotenko, S.V., Yilmaz, M., Mani, O., Zumkehr, J., Blaser, K., Akdis, C.A. Akdis, M. (2006) Regulation of T cells and cytokines by the interleukin-10 (IL-10)-family cytokines IL-19, IL-20, IL-22, IL-24 and IL-26. European Journal of Immunology, 36, 380.
33. Otkjaer, K., Kragballe, K., Funding, A.T., Clausen, J.T., Noerby, P.L., Steiniche, T. Iversen, L. (2005) The dynamics of gene expression of interleukin-19 and interleukin-20 and their receptors in psoriasis. British Journal of Dermatology, 153, 911.
34. Palella, F.J. Jr., Delaney, K.M., Moorman, A.C., Loveless, M.O., Fuhrer, J., Satten, G.A., Aschman, D.J. Holmberg, S.D. (1998) Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. New England Journal of Medicine, 338, 853.
35. Parrish-Novak, J., Xu, W., Brender, T., Yao, L., Jones, C., West, J. et al 2002) Interleukins 19, 20, and 24 signal through two distinct receptor complexes. Differences in receptor-ligand interactions mediate unique biological functions. Journal of Biological Chemistry, 277, 475173.
36. Peng, X.M., Huang, Y.S., Ma, H.H., Gu, L., Xie, Q.F. Gao, Z.L. (2006) Interleukin-10 promoter polymorphisms are associated with the mode and sequel of HBeAg seroconversion in patients with chronic hepatitis B virus infection. Liver International, 26, 326.
37. Pestka, S., Krause, C.D., Sarkar, D., Walter, M.R., Shi, Y. Fisher, P.B. (2004) Interleukin-10 and related cytokines and receptors. Annual Review of Immunology, 22, 929.
38. Rodriguez-Mendez, M.L., Gonzalez-Quintela, A., Aguilera, A. Barrio, E. (2000) Prevalence, patterns, and course of past hepatitis B virus infection in intravenous drug users with HIV-1 infection. American Journal of Gastroenterology, 95, 1316.
39. Salmon-Ceron, D., Lewden, C., Morlat, P., Bevilacqua, S., Jougla, E., Bonnet, F., Heripret, L., Costagliola, D., May, T. Chene, G. (2005) Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol. Journal of Hepatology, 42, 799.
40. Schaid, D.J., Rowland, C.M., Tines, D.E., Jacobson, R.M. Poland, G.A. (2002) Score tests for association between traits and haplotypes when linkage phase is ambiguous. American Journal of Human Genetics, 70, 425.
41. Seckin, D., Durusoy, C. Sahin, S. (2004) Concomitant vitiligo and psoriasis in a patient treated with interferon alfa-2a for chronic hepatitis B infection. Pediatric Dermatology, 21, 577.
42. Shin, H.D., Winkler, C., Stephens, J.C., Bream, J., Young, H., Goedert, J.J. et al 2000) Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10. Proceedings of the National Academy of Sciences of the USA, 97, 144672.
43. Shin, H.D., Park, B.L., Kim, L.H., Jung, J.H., Kim, J.Y., Yoon, J.H., Kim, Y.J. Lee, H.S. (2003) Interleukin 10 haplotype associated with increased risk of hepatocellular carcinoma. Human Molecular Genetics, 12, 901.
44. Shrestha, S., Strathdee, S.A., Galai, N., Oleksyk, T., Fallin, M.D., Mehta, S., Schaid, D., Vlahov, D., O'Brien, S.J. Smith, M.W. (2006) Behavioral risk exposure and host genetics of susceptibility to HIV-1 infection. Journal of Infectious Diseases, 193, 16.
45. Stenderup, K., Rosada, C., Worsaae, A., Clausen, J.T. Norman Dam, T. (2007) Interleukin-20 as a target in psoriasis treatment. Annals of New York Academy of Sciences, 1110, 368.
46. Thio, C.L., Seaberg, E.C., Skolasky, R. Jr., Phair, J., Visscher, B., Munoz, A. Thomas, D.L. (2002) HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet, 360, 1921.
47. Turner, D.M., Williams, D.M., Sankaran, D., Lazarus, M., Sinnott, P.J. Hutchinson, I.V. (1997) An investigation of polymorphism in the interleukin-10 gene promoter. European Journal of Immunogenetics, 24, 1.
48. Vicari, A.P. Trinchieri, G. (2004) Interleukin-10 in viral diseases and cancer: exiting the labyrinth? Immunological Reviews, 202, 223.
49. World Health Organization (2000) Hepatitis B Fact Sheet. WHO, Geneva, Switzerland.
50. Wolk, K., Kunz, S., Asadullah, K. Sabat, R. (2002) Cutting edge: immune cells as sources and targets of the IL-10 family members? Journal of Immunology, 168, 5397.
51. Xu, W. (2004) Interleukin-20. International Immunopharmacology, 4, 627.
52. Yachimski, P. Chung, R.T. (2005) Update on hepatitis B and C coinfection in HIV. Current Infectious Disease Reports, 7, 299.
53. Zaykin, D.V., Westfall, P.H., Young, S.S., Karnoub, M.A., Wagner, M.J. Ehm, M.G. (2002) Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Human Heredity, 53, 79.
54. Zhu, Q.R., Ge, Y.L., Gu, S.Q., Yu, H., Wang, J.S., Gu, X.H., Fei, L.E. Dong, Z.Q. (2005) Relationship between cytokines gene polymorphism and susceptibility to hepatitis B virus intrauterine infection. Chinese Medical Journal, 118, 1604.